Cascador Health will be present at this leading event for the European Allergy and Clinical Immunology community, discuss its renewed solutions portfolio and research propositions with life science clients. Furthermore, Cascador Respiratory (Galenus Health) will present an abstract of its CHRINOSOR research findings regarding the Dupilumab Effectiveness for CRSwNP in the Real World.